Hyalgan®(English)

HYALGAN® is a hyaluronic acid-based intra-articular injection formulated to address the discomfort and restricted mobility caused by knee osteoarthritis. By augmenting the joint’s natural synovial fluid, HYALGAN® provides a cushioning effect that helps reduce pain, improve range of motion, and potentially delay the need for more invasive interventions. Orthopedic surgeons, rheumatologists, and sports medicine specialists often integrate HYALGAN® into treatment plans when seeking a reliable option to relieve osteoarthritis symptoms.

In contrast to steroids, HYALGAN® focuses on replenishing the joint’s natural lubrication rather than solely targeting inflammation. This approach may lead to consistent, longer-term benefits, allowing patients to enjoy a more active lifestyle with less pain.

HYALGAN® is administered via intra-articular injection directly into the knee joint. Typically, it is delivered weekly for three to five consecutive weeks, depending on the severity of osteoarthritis and the patient’s response to therapy. Healthcare providers must follow an aseptic technique to reduce infection risk and ensure the solution is placed accurately within the joint space. Patients are advised to avoid intense physical activities or high-impact exercise for at least 48 hours following each injection, giving the product time to distribute throughout the joint and promote optimal lubrication.

Disclaimers:

– This is for use by licensed medical practitioners only and is not intended for self-administration.

– Contraindicated in patients with existing joint infections, severe knee inflammation, or allergy to avian proteins.

– Local joint pain, swelling, or mild synovial effusion can occur, though these effects are typically transient.

– Strict adherence to manufacturer instructions and regional healthcare regulations is necessary to maintain safety and efficacy.